GSK vs LH · P/E 13, $103.31B cap vs P/E 23, rev $13.95B
GlaxoSmithKline PLC ADR (GSK) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the GSK and LH stock pages for the full models.
Not investment advice.